Diabetology International

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)

Akira Shimada, Eiji Kawasaki, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Hiroshi Kajio, Junji Kozawa, Kazuma Takahashi, Daisuke Chujo, Shinsuke Noso, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Akihisa Imagawa, Hiroshi Ikegami

Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication

Atsushi Goto, Ken Ohashi, Mitsuhiko Noda, Hiroshi Noto, Kohjiro Ueki, Manami Inoue, Rimei Nishimura, Shin Takahashi, Tatsuya Ioka, Masanobu Oshima, Kazutoshi Fujibayashi, Akihito Tsuji, Makoto Kodaira, Akiko Tamakoshi, Koshi Mimori, Yuko Tanabe, Eiji Hara, Keitaro Matsuo, Yoshinori Murakami, Hirotaka Watada

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10)

Hideki Kamiya, Tatsuhito Himeno, Atsuko Watarai, Masayuki Baba, Rimei Nishimura, Naoko Tajima, Jiro Nakamura

Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 Diabetes

Masaji Sakaguchi

Exploring mechanisms underlying diabetes comorbidities and strategies to prevent vascular complications

Takayoshi Sasako

Effectiveness of management protocol for insulin balls in diabetics: a scoping review

Tomomi Horiguchi, Sayuri Nakamura, Yuko Matsui, Terumi Ueda, Naoko Kageura, Makoto Oe, Natsuko Seto, Toshihiko Yanagita, Junko Sugama

Impact of diabetic peripheral neuropathy on gait abnormalities in patients with type 2 diabetes mellitus

Samir H. Assaad Khalil, Hany Mohammed Ali El Deeb, Martin Otwang Dak Ajang, Nermin A. Osman, Noha Gaber Amin

Association of treatment satisfaction and physician trust with glycemic control among primary care patients with type 2 diabetes in Egypt

Hazem A. Sayed Ahmed, Nada Emad Abdelsalam, Anwar I. Joudeh, Ahmed Gharib Abdelrahman, Nahed Amen Eldahshan

Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study

Takashi Murata, Lise Lotte N. Husemoen, Satoko Nemoto, Munehide Matsuhisa

A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation

Suratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, Mayumi Nagashimada, Naoto Nagata, Yumi Takiyama

The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching

Toshihito Ando, Masaki Kondo, Yuriko Asada-Yamada, Miyuka Kawai, Emi Asano-Hayami, Tomohide Hayami, Mikio Motegi, Yohei Ejima, Eriko Nagao, Rina Kasagi, Hiromi Nakai-Shimoda, Saeko Asano, Makoto Kato, Yuichiro Yamada, Emiri Yura-Miura, Takahiro Ishikawa, Yukako Sugiura-Roth, Chika Kojima, Ena Naito, Tatsuhito Himeno, Shin Tsunekawa, Yoshiro Kato, Jiro Nakamura, Hideki Kamiya

Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus

Naoki Sakane, Yushi Hirota, Akane Yamamoto, Junnosuke Miura, Hiroko Takaike, Sari Hoshina, Masao Toyoda, Nobumichi Saito, Kiminori Hosoda, Masaki Matsubara, Atsuhito Tone, Satoshi Kawashima, Hideaki Sawaki, Tomokazu Matsuda, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata

The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes

Yasuaki Hayashino, Masashi Goto, Toshikazu Yamamoto, Satoru Tsujii, Hitoshi Ishii

The predictive role of serum uric acid levels before pregnancy in the development of gestational diabetes mellitus

Azam Ghanei, Golnaz Mohammadzade, Mohammadreza Gholami Banadkoki, Ali Emami Meybodi

Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab

Yuma Motomura, Shin Urai, Yushi Hirota, Naoki Takegawa, Hironori Bando, Masaaki Yamamoto, Hidenori Fukuoka, Masahiro Tsuda, Wataru Ogawa

Life-threatening coronary vasospasm in patients with type 2 diabetes with SGLT2 inhibitor-induced euglycemic ketoacidosis: a report of two consecutive cases

Junko Kawahara, Bunji Kaku, Kunimasa Yagi, Naotaka Kitagawa, Maki Yokoyama, Yusuke Wakabayashi, Satoko Senda, Hiroyuki Takata, Yoshio Hiraiwa

Correction: Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus

Hiroshi Takahashi, Yuka Suganuma, Takayuki Ohno, Rimei Nishimura

Acknowledgement to the Reviewers